Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,139Revenue $M7,670Net Margin (%)30.4Altman Z-Score8.1
Enterprise Value $M104,633EPS $2.4Operating Margin %37.6Piotroski F-Score8
P/E(ttm)45.3Beneish M-Score-2.5Pre-tax Margin (%)35.2Higher ROA y-yY
Price/Book15.610-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales13.85-y EBITDA Growth Rate %23.1Current Ratio4.6Lower Leverage y-yN
Price/Free Cash Flow38.0y-y EBITDA Growth Rate %71.3ROA % (ttm)15.3Higher Current Ratio y-yY
Dividend Yield %--PEG2.0ROE % (ttm)43.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M793ROIC % (ttm)46.7Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGKen Fisher 2015-06-30 Reduce$107.54 - $120.34
($114.34)
$ 132.5616%Reduce 2.40%224,399
CELGRonald Muhlenkamp 2015-03-31 Reduce-0.02%$110.51 - $128.5
($119.49)
$ 132.5611%Reduce 0.81%85,540
CELGJoel Greenblatt 2015-03-31 Add0.01%$110.51 - $128.5
($119.49)
$ 132.5611%Add 75.33%17,987
CELGMario Gabelli 2015-03-31 Reduce$110.51 - $128.5
($119.49)
$ 132.5611%Reduce 0.08%24,940
CELGKen Fisher 2015-03-31 Add$110.51 - $128.5
($119.49)
$ 132.5611%Add 1.14%229,918
CELGRonald Muhlenkamp 2014-12-31 Reduce-1.03%$86.38 - $118.68
($105.53)
$ 132.5626%Reduce 41.31%86,240
CELGJoel Greenblatt 2014-12-31 Buy 0.01%$86.38 - $118.68
($105.73)
$ 132.5625%New holding10,259
CELGGeorge Soros 2014-09-30 Sold Out -0.45%$83.13 - $96.21
($90.29)
$ 132.5647%Sold Out0
CELGJoel Greenblatt 2014-09-30 Sold Out -0.07%$83.13 - $96.21
($90.29)
$ 132.5647%Sold Out0
CELGKen Fisher 2014-09-30 Add0.02%$83.13 - $96.21
($90.29)
$ 132.5647%Add 77.12%232,137
CELGRonald Muhlenkamp 2014-06-30 Reduce-1.91%$68.45 - $86.8
($75.89)
$ 132.5675%Reduce 51.74%144,140
CELGGeorge Soros 2014-06-30 Buy 0.45%$68.45 - $86.8
($75.89)
$ 132.5675%New holding688,000
CELGJoel Greenblatt 2014-06-30 Buy 0.07%$68.45 - $86.8
($75.89)
$ 132.5675%New holding63,980
CELGKen Fisher 2014-06-30 Add0.01%$68.45 - $86.8
($75.89)
$ 132.5675%Add 75.59%131,064
CELGRonald Muhlenkamp 2014-03-31 Add0.05%$69.645 - $85.97
($79.19)
$ 132.5667%Add 1.29%298,650
CELGKen Fisher 2014-03-31 Add0.01%$69.645 - $85.97
($79.19)
$ 132.5667%Add 1591.80%74,642
CELGMario Gabelli 2014-03-31 Reduce$69.645 - $85.97
($79.19)
$ 132.5667%Reduce 3.58%21,540
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.19)
$ 132.5667%Sold Out0
CELGRonald Muhlenkamp 2013-12-31 Add0.12%$72.245 - $85.385
($79.13)
$ 132.5668%Add 2.87%294,850
CELGKen Fisher 2013-12-31 Reduce$72.245 - $85.385
($79.13)
$ 132.5668%Reduce 11.41%4,412
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Daniel Thomas Osee remarks 2015-07-13Sell30,156$120.789.87view
KAPLAN GILLADirector 2015-06-10Sell15,000$111.7418.76view
CASEY MICHAEL DDirector 2015-06-09Sell15,000$111.1819.36view
STEIN LAWRENCE VSee Remarks 2015-05-14Sell2,542$114.8515.54view
KAPLAN GILLADirector 2015-02-26Sell15,000$122.897.98view
CASEY MICHAEL DDirector 2015-02-25Sell15,000$123.197.72view
KARSEN PERRY Asee remarks 2015-02-11Sell27,896$120.1210.47view
Alles Mark JSee Remarks 2015-02-06Sell117,099$120.689.96view
STEIN LAWRENCE VSee Remarks 2015-01-15Sell26,666$120.0110.57view
KAPLAN GILLADirector 2015-01-02Sell45,536$113.4716.95view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
scottrade Jul 24 2015 
scottrade Jul 24 2015 
scottrade Jul 24 2015 
scottrade Jul 24 2015 
My Top 3 Pharma Stock Picks Jun 09 2015 
10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors Jun 04 2015 
Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
jee's porfolio May 23 2015 
Celgene’s Earnings Shine While Revenue Misses By An Inch In The First Quarter May 06 2015 
February Pick Of Biotech Stocks Feb 17 2015 

More From Other Websites
The Most Incredible Biotech Success Ever Faces Its Moment of Truth Jul 27 2015
Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks Jul 27 2015
Biogen: Buy the Stock Get the Pipeline for Free Jul 27 2015
Cramer's Stop Trading: Biogen & GrubHub Jul 27 2015
Short Sellers Back Off Major Biotechs Jul 27 2015
Celgene to acquire Receptos, advancing leadership in immune-inflammatory diseases Jul 27 2015
Biotech IPO Boom Gaining Thrust With NantKwest Debut Jul 24 2015
Who's leading the pack? Jul 24 2015
Biogen: Run Lola Run? Jul 24 2015
Biogen's Big-Volume Plunge Marks End Of 5-Year Run Jul 24 2015
Cramer's Mad Dash: Biogen's biotech blues Jul 24 2015
Silver Arrow’s Top Long Positions: Facebook Inc (FB), Celgene Corporation (CELG), Hertz Global... Jul 23 2015
Celgene (CELG) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
Celgene Q2 Earnings & Revenues In Line, Keeps View - Analyst Blog Jul 23 2015
Celgene's Q2 Earnings Call: Highlights & Analyst Commentary Jul 23 2015
Celgene's Adjusted Profit Rises on Revlimid Sales Jul 23 2015
Health care on a hot streak Jul 23 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK